⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
Canine EGFR/HER2 Peptide Cancer Immunotherapeutic
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Canine EGFR/HER2 Peptide Cancer Immunotherapeutic just got measured.
5/10 means Canine EGFR/HER2 Peptide Cancer Immunotherapeutic is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
About Canine EGFR/HER2 Peptide Cancer Immunotherapeutic
TheraJan, LLC produces an experimental canine EGFR/HER2 peptide immunotherapeutic. For supervised use by licensed veterinary oncologists. Not yet USDA approved.
Key Topics
Details
Industry: Healthcare
therajan.comAI Visibility Breakdown
3
Structured Data
7
Content Structure
8
Entity Clarity
3
E-E-A-T Signals
7
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Trust Is the Product. AI Is How You Build It at Scale.
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Canine EGFR/HER2 Peptide Cancer Immunotherapeutic.
Source & Attribution
Scored by Engagemii on June 30, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/therajan
Cite this score: Engagemii (2026). "AEO Score for Canine EGFR/HER2 Peptide Cancer Immunotherapeutic." Retrieved from https://engagemii.com/aeo/brands/therajan
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform